A recent study in eClinicalMedicine links tattoo ink exposure to a 21% higher risk of malignant lymphoma, particularly B-cell subtypes. Tattoo ink and laser removal may play significant roles in lymphoma development.
Lykos Therapeutics Makes Progress in Europe
The TDR Three Key Takeaways regarding Lykos Therapeutics and PTSD Therapy: Lykos Therapeutics achieves a major milestone with Phase 2 trials in Europe. MDMA-assisted therapy